Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 4/20 | 0.75 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.52 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL6545372 | 0.94 | SLC22A1 (0.75) | SLC22A1SLC22A2ALDH1A1TSHRTP53 | |
| Tetrabuthylammonium SCHEMBL28338553 | 0.94 | SLC22A1 (0.75) | SLC22A1SLC22A2ALDH1A1TSHRTP53 | |
| Tetrabuthylammonium SCHEMBL27575970 | 0.94 | SLC22A1 (0.75) | SLC22A1SLC22A2ALDH1A1TSHRTP53 | |
| Tetrabuthylammonium SCHEMBL28519848 | 0.90 | SLC22A1 (0.92) | SLC22A1SLC22A2ALDH1A1TSHRTP53 | |
| Tetrabuthylammonium SCHEMBL226110 | 0.90 | SLC22A1 (0.92) | SLC22A1SLC22A2ALDH1A1TSHRTP53 | |
| Tetrabuthylammonium SCHEMBL5144255 | 0.90 | SLC22A1 (0.92) | SLC22A1SLC22A2ALDH1A1TSHRTP53 | |
| Tetrabuthylammonium SCHEMBL466 | 0.90 | SLC22A1 (0.92) | SLC22A1SLC22A2ALDH1A1TSHRTP53 | |
| Tetrabuthylammonium SCHEMBL25325582 | 0.87 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TSHRTP53 | |
| Tetrabuthylammonium SCHEMBL209886 | 0.87 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TSHRTP53 | |
| Tetrabuthylammonium SCHEMBL7713436 | 0.87 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TSHRTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113264850-A | Synthetic method of nootropic ketonic A | 安徽农业大学 | 2021-08-17 | — | — | CN | disclosed |
| CN-108947859-B | Derivatives of kutkin dimer analogue JJA-D0 or pharmaceutically acceptable salts thereof, preparation method and application | 暨南大学 | 2021-06-11 | — | — | CN | disclosed |
| CN-106243014-A | A kind of benzopyrene derivant and its preparation method and application | 长春海谱润斯科技有限公司 | 2016-12-21 | — | — | CN | disclosed |
| US-20020041976-A1 | Novel compounds and their manufacture and use | ANDERSON SALLY (GB) | 2002-04-11 | — | — | US | disclosed |
| EP-1138713-A2 | Compounds and their manufacture and use | Sharp Kabushiki Kaisha (JP) | 2001-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020041976-A1 | Novel compounds and their manufacture and use | TRPC3, SLC43A1, TDO2 | SLC22A1 1059/4885SLC22A2 965/4885ALDH1A1 2053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.